AKARI THERAPEUTICS EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH PCT FILING FOR ADC PAYLOAD RELATED TO RNA SPLICING IN CANCERS

Reuters · 1d ago

Please log in to view news